Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | PLX-4720 | 0.031623 | uM | 5 | 1250.00 | 731.83 | 2045.00 | 1826.25 | 1.1198 | 1.1791 |
| SK-BR-3 | 0 | uM | 5 | 1250.00 | 731.83 | 1818.00 | 1826.25 | 0.9955 | 0.9932 | |
| SK-BR-3 | 0 | uM | 5 | 1250.00 | 731.83 | 1750.00 | 1826.25 | 0.9583 | 0.9364 | |
| SK-BR-3 | 0 | uM | 5 | 1250.00 | 731.83 | 1635.00 | 1826.25 | 0.8953 | 0.8391 | |
| SK-BR-3 | 0 | uM | 5 | 1250.00 | 731.83 | 1450.00 | 1826.25 | 0.7940 | 0.6791 | |
| SK-BR-3 | Etoposide | 0.01 | uM | 5 | 1250.00 | 731.83 | 1699.00 | 1826.25 | 0.9303 | 0.8935 |
| SK-BR-3 | Etoposide | 0.31623 | uM | 5 | 1250.00 | 731.83 | 1135.00 | 1826.25 | 0.6215 | 0.3946 |
| SK-BR-3 | PLX-4720 | 0.1 | uM | 5 | 1250.00 | 731.83 | 1714.00 | 1826.25 | 0.9385 | 0.9061 |
| SK-BR-3 | Nilotinib | 0.01 | uM | 5 | 1250.00 | 731.83 | 2122.00 | 1826.25 | 1.1619 | 1.2410 |
| SK-BR-3 | Nilotinib | 0.1 | uM | 5 | 1250.00 | 731.83 | 1855.00 | 1826.25 | 1.0157 | 1.0238 |
| SK-BR-3 | Etoposide | 19.9526 | uM | 5 | 1250.00 | 731.83 | 824.00 | 1826.25 | 0.4512 | 0.0941 |
| SK-BR-3 | PLX-4720 | 0.01 | uM | 5 | 1250.00 | 731.83 | 2196.00 | 1826.25 | 1.2025 | 1.3000 |
| SK-BR-3 | PLX-4720 | 3.1623 | uM | 5 | 1250.00 | 731.83 | 2021.00 | 1826.25 | 1.1066 | 1.1597 |
| SK-BR-3 | Nilotinib | 10 | uM | 5 | 1250.00 | 731.83 | 1526.00 | 1826.25 | 0.8356 | 0.7454 |
| SK-BR-3 | NVP-TAE684 | 0.0016596 | uM | 5 | 1250.00 | 731.83 | 2179.00 | 1826.25 | 1.1932 | 1.2865 |
| SK-BR-3 | Nilotinib | 1 | uM | 5 | 1250.00 | 731.83 | 1980.00 | 1826.25 | 1.0842 | 1.1264 |
| SK-BR-3 | NVP-TAE684 | 0.1 | uM | 5 | 1250.00 | 731.83 | 2038.00 | 1826.25 | 1.1159 | 1.1734 |
| SK-BR-3 | PLX-4720 | 10 | uM | 5 | 1250.00 | 731.83 | 1817.00 | 1826.25 | 0.9949 | 0.9923 |
| SK-BR-3 | Nilotinib | 19.9526 | uM | 5 | 1250.00 | 731.83 | 1221.00 | 1826.25 | 0.6686 | 0.4740 |
| SK-BR-3 | 0 | uM | 5 | 1250.00 | 731.83 | 1907.00 | 1826.25 | 1.0442 | 1.0667 | |
| SK-BR-3 | NVP-TAE684 | 3.1623 | uM | 5 | 1250.00 | 731.83 | 872.00 | 1826.25 | 0.4775 | 0.1421 |
| SK-BR-3 | Etoposide | 0.0033113 | uM | 5 | 1250.00 | 731.83 | 2002.00 | 1826.25 | 1.0962 | 1.1443 |
| SK-BR-3 | PLX-4720 | 19.9526 | uM | 5 | 1250.00 | 731.83 | 1843.00 | 1826.25 | 1.0092 | 1.0139 |
| SK-BR-3 | Etoposide | 3.1623 | uM | 5 | 1250.00 | 731.83 | 921.00 | 1826.25 | 0.5043 | 0.1904 |
| SK-BR-3 | NVP-TAE684 | 10 | uM | 5 | 1250.00 | 731.83 | 734.00 | 1826.25 | 0.4019 | 0.0022 |